首页> 外文期刊>Journal of Analytical Methods in Chemistry >Development and Validation of a Versatile UPLC-PDA Method for Simultaneous Determination of Paracetamol, Tizanidine, Aceclofenac, and Nimesulide in Their New Combinations
【24h】

Development and Validation of a Versatile UPLC-PDA Method for Simultaneous Determination of Paracetamol, Tizanidine, Aceclofenac, and Nimesulide in Their New Combinations

机译:多功能UPLC-PDA方法同时测定扑热息痛,三氮胺酮,醋氯芬酸和尼美砜的开发和验证

获取原文
           

摘要

A simple, rapid, and validated UPLC method was developed for the simultaneous quantitation of paracetamol (PAR), tizanidine (TIZ), aceclofenac (ACF), and nimesulide (NIM) either in pure forms or in their different tablet dosage forms. Chromatographic separation was attained on an ACQUITY UPLC? BEH C18 column (100?mm?×?2.1?mm, 1.7?m) with a mobile phase consisting of 20?mM phosphate buffer (pH 7.0)??acetonitrile in the proportion (60??40 /) isocratically pumped at a flow rate of 1.25?mL·min?1, and detection was monitored at 305?nm. All analytes were separated simultaneously at a retention time (tr) of 1.42, 2.31, 3.63, and 5.62?min for PAR, TIZ, ACF, and NIM, respectively, with a total run time less than 6.0?min. The proposed method was validated according to ICH guidelines with respect to accuracy, precision, linearity, limit of detection, limit of quantitation, and robustness. Linearity was obtained over a concentration range of 81.25–487.5, 0.5–3.5, 25–150, and 25–150?μg·mL?1 for PAR, TIZ, ACF, and NIM, respectively. The development method can be successfully employed in QC laboratories for the routine analysis of the investigated drugs in their new combination.
机译:开发了一种简单,快速和验证的UPLC方法,用于同时定量扑热氨基醇(PAR),钛烷(TIZ),乙烯烯烃(ACF)和尼米丁烷(ACF)和Nimesulide(Nim),其形式或其不同的片剂剂型。获得多种UPLC达到色谱分离?具有由20·mm磷酸盐缓冲液(pH7.0)组成的移动相的移动相(100Ωmm,1.7m,1.7×m)。乙腈(60Ω40/)在A中的比例(60 ?? 40 /)以a流速为1.25?m1·min?1,并在305℃下监测检测。将所有分析物同时分离为1.42,2.31,3.63和5.62Ω分别用于PAR,TIZ,ACF和NIM,总运行时间小于6.0≤min。根据ICH指南验证了所提出的方法,验证了关于准确性,精度,线性度,检测极限,定量限制和鲁棒性的准则。在81.25-487.5,0.5-3.5,25-150和25-150Ω的浓度范围内获得线性度分别用于PAR,TIZ,ACF和NIM的25-150×1μg·mL·ml·1。可以在QC实验室中成功地使用开发方法,以便在新组合中进行调查药物的常规分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号